These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 18403236)

  • 1. Molecular and biological characterization of histidine triad protein in group A streptococci.
    Kunitomo E; Terao Y; Okamoto S; Rikimaru T; Hamada S; Kawabata S
    Microbes Infect; 2008 Apr; 10(4):414-23. PubMed ID: 18403236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HtpS, a novel immunogenic cell surface-exposed protein of Streptococcus suis, confers protection in mice.
    Shao Z; Pan X; Li X; Liu W; Han M; Wang C; Wang J; Zheng F; Cao M; Tang J
    FEMS Microbiol Lett; 2011 Jan; 314(2):174-82. PubMed ID: 21133988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar ability of FbaA with M protein to elicit protective immunity against group A streptococcus challenge in mice.
    Ma CQ; Li CH; Wang XR; Zeng RH; Yin XL; Feng HD; Wei L
    Cell Mol Immunol; 2009 Feb; 6(1):73-7. PubMed ID: 19254483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective immunity against Streptococcus pyogenes challenge in mice after immunization with fibronectin-binding protein.
    Terao Y; Okamoto S; Kataoka K; Hamada S; Kawabata S
    J Infect Dis; 2005 Dec; 192(12):2081-91. PubMed ID: 16288371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FbaA- and M protein-based multi-epitope vaccine elicits strong protective immune responses against group A streptococcus in mouse model.
    Ma C; Liu Z; Li W; Qian X; Zhang S; Gao X; Jiang S; Wei L
    Microbes Infect; 2014 May; 16(5):409-18. PubMed ID: 24704476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis.
    Adamou JE; Heinrichs JH; Erwin AL; Walsh W; Gayle T; Dormitzer M; Dagan R; Brewah YA; Barren P; Lathigra R; Langermann S; Koenig S; Johnson S
    Infect Immun; 2001 Feb; 69(2):949-58. PubMed ID: 11159990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus.
    Olive C; Ho MF; Dyer J; Lincoln D; Barozzi N; Toth I; Good MF
    J Infect Dis; 2006 Jun; 193(12):1666-76. PubMed ID: 16703510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-informed design of an enzymatically inactive vaccine component for group A Streptococcus.
    Henningham A; Ericsson DJ; Langer K; Casey LW; Jovcevski B; Chhatwal GS; Aquilina JA; Batzloff MR; Kobe B; Walker MJ
    mBio; 2013 Aug; 4(4):. PubMed ID: 23919999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of an antigen I/II family protein produced by group A Streptococcus.
    Zhang S; Green NM; Sitkiewicz I; Lefebvre RB; Musser JM
    Infect Immun; 2006 Jul; 74(7):4200-13. PubMed ID: 16790795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and assessment of new vaccine candidates for group A streptococcal infections.
    McMillan DJ; Batzloff MR; Browning CL; Davies MR; Good MF; Sriprakash KS; Janulczyk R; Rasmussen M
    Vaccine; 2004 Jul; 22(21-22):2783-90. PubMed ID: 15246612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of the coverage capacity of the StreptInCor candidate vaccine against Streptococcus pyogenes.
    De Amicis KM; Freschi de Barros S; Alencar RE; Postól E; Martins Cde O; Arcuri HA; Goulart C; Kalil J; Guilherme L
    Vaccine; 2014 Jul; 32(32):4104-10. PubMed ID: 23994376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.
    Seepersaud R; Hanniffy SB; Mayne P; Sizer P; Le Page R; Wells JM
    Infect Immun; 2005 Mar; 73(3):1671-83. PubMed ID: 15731068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against group A streptococcal infection by vaccination with self-adjuvanting lipid core M protein peptides.
    Olive C; Hsien K; Horváth A; Clair T; Yarwood P; Toth I; Good MF
    Vaccine; 2005 Mar; 23(17-18):2298-303. PubMed ID: 15755615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population.
    Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S
    BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral immunization of mice with engineered Lactobacillus gasseri NM713 strain expressing Streptococcus pyogenes M6 antigen.
    Mansour NM; Abdelaziz SA
    Microbiol Immunol; 2016 Aug; 60(8):527-32. PubMed ID: 27301486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models.
    Rivera-Hernandez T; Pandey M; Henningham A; Cole J; Choudhury B; Cork AJ; Gillen CM; Ghaffar KA; West NP; Silvestri G; Good MF; Moyle PM; Toth I; Nizet V; Batzloff MR; Walker MJ
    mBio; 2016 Jun; 7(3):. PubMed ID: 27302756
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic immunization with streptococcal immunoglobulin-binding protein Sib 35 induces protective immunity against group: a Streptococcus challenge in mice.
    Okamoto S; Tamura Y; Terao Y; Hamada S; Kawabata S
    Vaccine; 2005 Sep; 23(40):4852-9. PubMed ID: 15990202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and protective efficacy induced by self-amplifying mRNA vaccines encoding bacterial antigens.
    Maruggi G; Chiarot E; Giovani C; Buccato S; Bonacci S; Frigimelica E; Margarit I; Geall A; Bensi G; Maione D
    Vaccine; 2017 Jan; 35(2):361-368. PubMed ID: 27939014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial Synthetic Peptide Vaccine Strategy Protects against Hypervirulent CovR/S Mutant Streptococci.
    Pandey M; Mortensen R; Calcutt A; Powell J; Batzloff MR; Dietrich J; Good MF
    J Immunol; 2016 Apr; 196(8):3364-74. PubMed ID: 26969753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of new candidate vaccine antigens made by Streptococcus pyogenes: purification and characterization of 16 putative extracellular lipoproteins.
    Lei B; Liu M; Chesney GL; Musser JM
    J Infect Dis; 2004 Jan; 189(1):79-89. PubMed ID: 14702157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.